Molecular BiologybioRxivPreprint
Levosimendan Ameliorates Adverse Pulmonary Vascular Remodeling in Group-2 Pulmonary Hypertension.
Antonella Abi-Sleimen, Ruaa Al‐Qazazi, Yann Grobs…·François Potus
This study develops preclinical models of Group-2 pulmonary hypertension and shows that levosimendan improves cardiac function and reduces pulmonary vascular inflammation and remodeling.
DOI 10.1101/2025.10.23.684000